These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The limitations of current therapy in peptic ulcer disease. Salena BJ; Hunt RH Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747 [TBL] [Abstract][Full Text] [Related]
47. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists]. Contraşiu P; Calinici V Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650 [No Abstract] [Full Text] [Related]
48. [Pharmacologic treatment of ulcers]. Honorato Pérez J; Azanza Perea JR; Cuena Boy R Rev Med Univ Navarra; 1984 Jun; 28(2):53-8. PubMed ID: 6149611 [No Abstract] [Full Text] [Related]
50. [Financial cost of the treatment of peptic ulcer]. Castro Lde P; de Souza ZP; Ribeiro Tde C; Coelho LG; Avelar CD AMB Rev Assoc Med Bras; 1986; 32(1-2):21-4. PubMed ID: 2878471 [No Abstract] [Full Text] [Related]
51. Your CE topic this month (No. 9). Peptic ulcer disease. Perentesis GP; Kirschenbaum HL; Piltz GW J Pract Nurs; 1983; 33(8):35-43. PubMed ID: 6140312 [No Abstract] [Full Text] [Related]
52. [Conservative treatment of uncomplicated peptic ulcer by various methods]. Sülle C; Murasko V; Balalükin A; Maljarova L; Lapsina S; Zsuravlev A Orv Hetil; 1985 Mar; 126(13):757-61. PubMed ID: 2859568 [No Abstract] [Full Text] [Related]
53. Cimetidine: a reivew of clinical trials. Cipolle RJ; Navarro RP; Fischer RP Minn Med; 1977 Jun; 60(5):446-9. PubMed ID: 17064 [No Abstract] [Full Text] [Related]
54. [Randomized double-blind placebo-controlled study of drugs with anti-ulcer action and their use in associated pathology]. Ivashkin VT; Minasian GA Ter Arkh; 1988; 60(1):78-83. PubMed ID: 3129806 [TBL] [Abstract][Full Text] [Related]
55. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings]. Gostishchev VK; Evseev MA Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681 [TBL] [Abstract][Full Text] [Related]
57. [Drug therapy and therapeutic tactics in gastroduodenal ulcer]. Grigor'ev PIa; Isakov VA; Iakovenko EP Ter Arkh; 1988; 60(8):118-26. PubMed ID: 2906485 [No Abstract] [Full Text] [Related]
58. [Surgery of peptic ulcer 10 years after the introduction of anti-H2 agents]. Bartolotta M; Carditello A Ann Gastroenterol Hepatol (Paris); 1988; 24(3):107-9. PubMed ID: 2899990 [TBL] [Abstract][Full Text] [Related]
59. [Effect of M-cholinolytics and histamine H2 receptor blockaders on the acid-peptide factor in patients with peptic ulcer]. Masevich TsG; Shastina NN Klin Med (Mosk); 1987 Oct; 65(10):73-6. PubMed ID: 2892966 [No Abstract] [Full Text] [Related]
60. [Current trends in medical therapy of gastroduodenal ulcer]. Grassi M; Fraioli A; Messina B Clin Ter; 1987 Dec; 123(6):475-86. PubMed ID: 2902954 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]